Ocular Therapeutix (OCUL) Long-Term Debt Repayments (2013 - 2021)
Ocular Therapeutix (OCUL) recorded quarterly Long-Term Debt Repayments of $2.1 million in Q2 2021, little changed quarter-over-quarter from $2.1 million in Q1 2021.
Ocular Therapeutix (OCUL) Long-Term Debt Repayments (2013 - 2021) Analysis & Trends
Ocular Therapeutix's Long-Term Debt Repayments history runs 5 years deep, the most recent figure standing at $2.1 million for Q2 2021.
- In Q2 2021, Long-Term Debt Repayments changed N/A year-over-year to $2.1 million; the TTM figure through Dec 2023 stood at $2.1 million (changed N/A YoY), while the FY2023 annual figure was $26.1 million, changed N/A from the prior year.
- Long-Term Debt Repayments was $2.1 million for Q2 2021 at Ocular Therapeutix, roughly flat from $2.1 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $2.1 million in Q2 2021 to a low of $1.0 million in Q1 2018.
- Historically, Long-Term Debt Repayments has averaged $1.6 million across 3 years, with a median of $1.5 million in 2018.
- Biggest YoY gain for Long-Term Debt Repayments was 20.85% in 2018; the steepest drop was 20.85% in 2018.
- A 3-year view of Long-Term Debt Repayments shows it stood at $1.3 million in 2017, then increased by 18.69% to $1.5 million in 2018, then surged by 35.06% to $2.1 million in 2021.
- The last three Long-Term Debt Repayments figures came in at $2.1 million (Q2 2021), $2.1 million (Q1 2021), and $1.5 million (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -21,671.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 9.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 2.08 Mn |
| Jun 30, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Mar 31, 2021 | 2.08 Mn |
| Dec 31, 2018 | 1.54 Mn |
| Dec 31, 2018 | 1.54 Mn |
| Sep 30, 2018 | 1.54 Mn |
| Sep 30, 2018 | 1.54 Mn |
| Jun 30, 2018 | 1.54 Mn |
| Jun 30, 2018 | 1.54 Mn |
| Mar 31, 2018 | 1.03 Mn |
| Mar 31, 2018 | 1.03 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Jun 30, 2014 | 1.82 Mn |
| Jun 30, 2014 | 1.82 Mn |
| Mar 31, 2014 | 454,000.00 |
| Mar 31, 2014 | 454,000.00 |
| Dec 31, 2013 | 454,000.00 |
| Dec 31, 2013 | 454,000.00 |